Technetium 99m Dimercaptosuccinic Acid Scintigraphy in Medullary Carcinoma of the Thyroid

Abstract

Get full access to this article

View all access options for this article.

References

Hoefnagel

Delprat

Zanin

Van Der Schoot

. New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma. Clin Nucl Med 1988; 13: 159–65.

Clarke

SEM

Lazarus

Wraight

Sampson

Maisey

. Pentavalent [^99mTc]DMSA, [¹³¹I]MIBG, and [^99mTc]MDP — an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid. J Nucl Med 1988; 29: 33–8.

Guerra

Pizzocaro

Terzi

. New tracers for the imaging of the medullary thyroid carcinoma. Nucl Med Commun 1989; 10: 285–95.

Ohta

Yamomoto

Endo

Ohta

. A new imaging agent for medullary carcinoma of the thyroid. J Nucl Med 1984; 25: 323–5.

Miyauchi

Endo

Ohta

. 99^mTc(V)-dimercaptosuccinic acid scintigraphy for medullary thyroid carcinoma. World J Surg 1986; 10: 640–5.

Ramamoorthy

Shetye

Pandey

. Preparation and evaluation of ^99mTc(V)-DMSA complex: studies in medullary carcinoma of the thyroid. Eur J Nucl Med 1987; 12: 623–8.

Clarke

SEM

Lazarus

Mistry

Maisey

. The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid. Br J Radiol 1987; 60: 1089–92.

Udelsman

Mojiminiyi

Soper

NDW

. Medullary carcinoma of the thyroid: management of persistent hypercalcitonemia utilizing [^99mTc](v) dimercaptosuccinic acid scintigraphy. Br J Surg 1989; 76: 1278–81.

Mojiminiyi

Udelsman

Soper

NDW

Shepstone

Dudley

. Pentavalent Tc-99m DMSA scintigraphy. Prospective evaluation of its role in the management of patients with medullary carcinoma of the thyroid. Clin Nucl Med 1991; 16: 259–62.

10.

Guerra

Pizzocaro

. The use of 99mTc(V)DMSA as imaging for the medullary thyroid carcinoma (MCT). J Nucl Med Allied Sci 1988; 32: 242–7.